THE BUYER'S GUIDE / SELECTION
Choosing Tylosin Tartrate15mg +Doxycycline HCL10mg +Bromhexine HCL0.1mg tablet: Application Fit and Specification Checks
This guide helps procurement teams, distributors, and veterinary buyers assess whether the Tylosin Tartrate15mg +Doxycycline HCL10mg +Bromhexine HCL0.1mg tablet suits their sourcing requirements. It covers the product's confirmed composition, therapeutic indications, target species (pigeons), dosage parameters, packaging format, and key selection criteria — enabling buyers to match verified specifications against their needs before placing an order.
Species and indication fit: The confirmed product label covers pigeons with intestinal and bronchial bacterial infections caused by Mycoplasma and Chlamydia. Buyers must confirm target species and pathogen scope match the label before ordering.
Active ingredient concentrations and regulatory compliance: Confirmed levels are Tylosin Tartrate 15 mg, Doxycycline HCL 10 mg, and Bromhexine HCL 0.1 mg per tablet. Buyers in regulated markets should verify whether these concentrations require a veterinary prescription, import permit, or in-country registration.
Dosage administration method and operational feasibility: One oral tablet per pigeon per 400–500 g body weight for 7–10 days. Confirm that individual oral tablet dosing is operationally practical for the intended flock management setup.
Storage and distribution conditions: The product must be stored in a cool, dry place per the approved label. Buyers should confirm that their supply chain and destination storage can maintain these conditions.
Packaging format compatibility: Commercial unit is 10 tablets × 10 blisters per box (100 tablets/box). Verify that this pack size is compatible with resale or treatment-program volumes.
What Is This Combination Tablet?
The Tylosin Tartrate15mg +Doxycycline HCL10mg +Bromhexine HCL0.1mg tablet is a veterinary oral dosage form that combines two complementary antibiotics with a mucolytic agent in a single tablet. Each tablet contains:
- Tylosin Tartrate — 15 mg (macrolide antibiotic)
- Doxycycline HCL — 10 mg (tetracycline-class antibiotic)
- Bromhexine HCL — 0.1 mg (mucolytic / secretolytic)
- Excipients q.s.
The product is manufactured in China and supplied by Shijiazhuang Roc Cattle I&E Trading Co.,Ltd as part of its veterinary animal health range. It carries the label designation For Veterinary Use Only and is NOT FOR HUMAN USE.
Confirmed Indications
The Tylosin Tartrate15mg +Doxycycline HCL10mg +Bromhexine HCL0.1mg tablet is indicated for the treatment of bacterial infections of the intestine and bronchial tubes in pigeons caused by organisms sensitive to Doxycycline and/or Tylosin — specifically:
- Mycoplasma spp.
- Chlamydia spp.
The three-way combination addresses both infection and mucus management:
| Active | Class | Primary Role in the Formula |
|---|---|---|
| Tylosin Tartrate 15 mg | Macrolide antibiotic | Targets Mycoplasma and gram-positive respiratory pathogens |
| Doxycycline HCL 10 mg | Tetracycline antibiotic | Broad-spectrum cover including Chlamydia and intracellular pathogens |
| Bromhexine HCL 0.1 mg | Mucolytic agent | Reduces mucus viscosity, facilitates secretion clearance and aids breathing |
The dual antibiotic pairing provides complementary antibacterial coverage while Bromhexine supports mucociliary clearance — addressing both the underlying infection and mucus congestion simultaneously.
Target Species and Dosage
This product is formulated specifically for pigeons. The dosage is:
One tablet per pigeon (per 400–500 g of body weight), administered orally, for 7–10 days.
Buyers sourcing for other avian species or non-avian livestock should confirm with a qualified veterinarian whether these active concentrations and the dosage form are appropriate, as the approved labelling covers pigeons only.
Packaging Specification
The confirmed commercial packaging is:
- 10 tablets × 10 blisters per box (100 tablets/box)
Selection Criteria Checklist
Use the following criteria to determine whether this tablet meets your procurement requirements:
1. Species and Indication Fit
- The label indication covers pigeons with intestinal and bronchial bacterial infections.
- If your operation treats pigeons affected by Mycoplasma or Chlamydia, the dual antibiotic combination directly targets those pathogens.
- If your target species differs, seek veterinary guidance before ordering.
2. Active Ingredient Concentrations and Regulatory Compliance
- Confirmed concentrations: Tylosin Tartrate 15 mg, Doxycycline HCL 10 mg, Bromhexine HCL 0.1 mg per tablet.
- Compare these concentrations against local regulatory requirements or pharmacopoeial standards for the importing country.
- Buyers in regulated markets (US, EU, Middle East, Southeast Asia) should verify whether these concentrations require a veterinary prescription or import permit.
3. Dosage Administration Method and Operational Feasibility
- Oral tablet; one tablet per bird per dosing event.
- Suitable for operations where birds are individually handled or individually dosed.
- This is not a water-soluble powder or premix — confirm that individual oral dosing is operationally practical for your flock size.
4. Treatment Duration and Withdrawal Period
- The approved course is 7–10 days.
- Confirm that this duration aligns with your flock management protocols and any local withdrawal period requirements.
5. Storage and Distribution Conditions
- The approved label requires storage in a cool, dry place.
- Verify that your distribution chain and destination storage facilities can maintain these conditions, particularly for shipments to warm or humid climates.
6. Import Regulatory Status
- The product is made in China and labelled for veterinary use.
- Import registration, permitted antibiotic lists, and local veterinary medicine licensing vary by country.
- Confirm regulatory acceptance of Tylosin and Doxycycline at these concentrations in the destination market before placing an order.
7. Packaging Format Compatibility
- Commercial unit: 10 tablets × 10 blisters per box (100 tablets/box).
- Verify that this pack size aligns with your resale, dispensing, or treatment-program volumes.
When This Product Is a Good Fit
- You source veterinary products for pigeon breeders, racing pigeon clubs, or avian veterinary practices.
- Your buyers require a ready-to-administer oral tablet that addresses Mycoplasma and Chlamydia-related respiratory and intestinal disease in pigeons.
- A combined antibacterial + mucolytic action in a single dosage form is operationally preferred, reducing the need for concurrent medications.
- Your distribution or retail format is compatible with blister-pack tablets in 100-tablet boxes.
When to Evaluate Alternatives
- Your target animal species is not pigeon, or the bacterial pathogens are outside the scope of Doxycycline and Tylosin coverage.
- Your market requires a water-soluble formulation for flock-wide water medication.
- Local regulations restrict importation or use of tetracycline or macrolide antibiotics without special permits.
- You require confirmed certifications, test reports, or pharmacovigilance documentation — contact Shijiazhuang Roc Cattle I&E Trading Co.,Ltd directly for those supporting documents.
Buyer Summary
The Tylosin Tartrate15mg +Doxycycline HCL10mg +Bromhexine HCL0.1mg tablet is a purpose-built veterinary oral tablet for treating pigeon intestinal and bronchial bacterial infections. Its three-way formula combining a macrolide antibiotic, a tetracycline antibiotic, and a mucolytic is confirmed in the product specification for Mycoplasma and Chlamydia indications. Procurement teams should verify species fit, active concentrations against local pharmacopoeial standards, import regulatory status, and storage compatibility as the primary selection criteria before committing to an order. For pricing, delivery terms, certifications, and minimum order quantities, contact Shijiazhuang Roc Cattle I&E Trading Co.,Ltd directly.
THE COMPANY
Shijiazhuang Roc Cattle I&E Trading Co.,Ltd
RC GROUP is mainly produce feed premix , animal herbal medicine and animal health etc. We are comprehensive company which involves the research, development, production, and sells. We have ourself factory , can finish the order quickly and the quantity is assured.
About Us ↗Visit company website ↗YOUR NEXT STEP
Bring your brief. Start a useful conversation.
Use case, specification, quantity and delivery window: make the next conversation specific.
Post time: October 27, 2026
